Orange Book product · Brand (NDA)
SALUTENSIN
HYDROFLUMETHIAZIDE; RESERPINE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
HYDROFLUMETHIAZIDE; RESERPINE
Strength
50MG;0.125MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 012359
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1985RESERPINE AND HYDROFLUMETHIAZIDEGeneric (ANDA)
ANDA 088907 · PAR PHARM
- 1985RESERPINE AND HYDROFLUMETHIAZIDEGeneric (ANDA)
ANDA 088932 · IVAX PHARMS
- 1983HYDROFLUMETHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088195 · USL PHARMA
- 1983HYDROFLUMETHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088127 · WATSON LABS
- 1983HYDROFLUMETHIAZIDE AND RESERPINEGeneric (ANDA)
ANDA 088110 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
